Sort
82,697 grants matching “vaccine development”
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
$4,149,892John P Moore · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
Basic and Applied Studies in Development of an AIDS Vaccine
$4,139,375Marjorie Robert-Guroff · Basic Sciences · Z01 · FY2007 · CA
Project 1 â Development of Orally Bioavailable beta-CoV Inhibitors
$4,139,330Richard K. Plemper · Emory University · U19 · FY2022 · AI
Infectious Diseases Fellowship Program
$4,138,603Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2023 · AI
Harvard University Center for AIDS Research
$4,137,237Bruce D Walker · Harvard University · P30 · FY2015 · AI
HIV Monoclonal Antibody Studies
$4,135,637Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
HIV Vaccine Studies
$4,135,637Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Optimizing the Immunogenicity of MVA-Based AIDS Vaccines
$4,133,290Emory University · U19 · FY2004 · AI
Global innate immune responses to HIV-1 infection
$4,132,294Sumit K Chanda · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2014 · AI
Clinical Trials Units for NIAID Networks (UM1)
$4,132,035Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2019 · AI
Center for AIDS Research at Emory University
$4,129,580Carlos Del Rio · Emory University · P30 · FY2019 · AI
UAB Center for AIDS Research
$4,129,317Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2011 · AI
UCSF HIV Clinical Trials Unit
$4,128,866Diane V Havlir · University Of California, San Francisco · UM1 · FY2013 · AI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$4,122,850John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
HIV Preventive Vaccine Studies
$4,122,073Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
$4,121,081Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · UG3 · FY2018 · DA
Smallpox subunit vaccine in the C-PERL expression system
$4,118,394Chesapeake Perl · UC1 · FY2005 · AI
HIV Prevention Trials Network: Network Laboratory
$4,116,871Susan H Eshleman · Johns Hopkins University · U01 · FY2009 · AI
Determinants of HIV Transmission
$4,112,421Susan Little · University Of California, San Diego · P01 · FY2009 · AI
Operations and Management support component
$4,111,098Barton F Haynes · Duke University · UM1 · FY2014 · AI
BREAD: Toward Development of a Vaccine for Contagious Bovine Pleuropneumonia (CBPP)
$4,110,805Sanjay Vashee · J. Craig Venter Institute, Inc. · · FY2011 · BIO
Phase I HIV vaccine trial with DNAALVAC-HIV gp120 delta V1 vaccines
$4,110,031Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
COVID-19 Clinical Support and Research
$4,108,341Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
$4,104,830George M Shaw · University Of Pennsylvania · P01 · FY2023 · AI
Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
$4,104,799Georgia D Tomaras · Duke University · P01 · FY2020 · AI